Cardinal Health, Inc. (CAH)
NYSE: CAH · IEX Real-Time Price · USD
103.54
+0.17 (0.16%)
At close: Apr 24, 2024, 4:00 PM
103.31
-0.23 (-0.22%)
After-hours: Apr 24, 2024, 7:19 PM EDT
Cardinal Health Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Cardinal Health stock have an average target of 103, with a low estimate of 85 and a high estimate of 125. The average target predicts a decrease of -0.52% from the current stock price of 103.54.
Analyst Consensus: Buy
* Price targets were last updated on Feb 26, 2024.
Analyst Ratings
The average analyst rating for CAH stock from 15 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
| Buy | 2 | 2 | 3 | 4 | 4 | 4 |
| Hold | 9 | 8 | 8 | 8 | 8 | 8 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 13 | 15 | 15 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Initiates $125 | Buy | Initiates | $125 | +20.73% | Feb 26, 2024 |
| Argus Research | Argus Research | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 9, 2024 |
| UBS | UBS | Strong Buy Maintains $122 → $125 | Strong Buy | Maintains | $122 → $125 | +20.73% | Feb 5, 2024 |
| UBS | UBS | Strong Buy Maintains $114 → $122 | Strong Buy | Maintains | $114 → $122 | +17.83% | Jan 29, 2024 |
| Barclays | Barclays | Buy Initiates $117 | Buy | Initiates | $117 | +13.00% | Jan 3, 2024 |
Financial Forecast
Revenue This Year
229.22B
from 205.01B
Increased by 11.81%
Revenue Next Year
248.64B
from 229.22B
Increased by 8.47%
EPS This Year
7.37
from 1.00
Increased by 636.93%
EPS Next Year
8.09
from 7.37
Increased by 9.74%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 240.5B | 263.6B | 286.1B | 309.9B | 334.0B |
| Avg | 229.2B | 248.6B | 267.8B | 286.3B | 304.7B |
| Low | 220.2B | 235.8B | 249.5B | 266.4B | 279.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 17.3% | 15.0% | 15.1% | 15.7% | 16.6% |
| Avg | 11.8% | 8.5% | 7.7% | 6.9% | 6.4% |
| Low | 7.4% | 2.9% | 0.3% | -0.5% | -2.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.72 | 8.85 | 9.93 | 9.33 | 9.87 |
| Avg | 7.37 | 8.09 | 8.80 | 8.49 | 8.86 |
| Low | 7.00 | 7.50 | 7.34 | 7.77 | 7.99 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 672.2% | 20.1% | 22.8% | 6.1% | 16.2% |
| Avg | 636.9% | 9.7% | 8.8% | -3.5% | 4.3% |
| Low | 599.7% | 1.7% | -9.2% | -11.7% | -6.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.